Two of the three hormones retatrutide mimics are already available in FDA-approved weight loss medications, so the patient who was granted early access likely sought benefits primarily stemming from the third hormone, which activates the livers glucagon receptors
Some individuals may be able to manage many mild side effects with supportive lifestyle adjustments, such as eating smaller meals, avoiding heavy or fatty foods, and staying well hydrated
GIP and GLP1 are neuroprotective in preclinical models of neurodegenerative disease
However, it is still under study and should not be seen as a substitute for a balanced diet or a healthy lifestyle
The titration protocol (starting at 2 mg and increasing every four weeks) is essential for tolerability
Protein-first eating Prioritizing protein at every meal enhances appetite suppression through two mechanisms